p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors.
作者： J Sonnemann , C Marx , S Becker , S Wittig , C D Palani
DOI: 10.1038/BJC.2013.742
关键词: Histone deacetylase 、 Mdm2 、 Histone deacetylase inhibitor 、 Bortezomib 、 Cell cycle 、 Cell growth 、 Cancer research 、 Apoptosis 、 Caspase 、 Biology
摘要: p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors
nature.com
elsevier.com
sci-hub.se 参考文章(48)
Dominic A. Scudiero, Kurt W. Kohn, John N. Weinstein, Stephen Friend, Joany Jackman, Albert J. Fornace, Timothy G. Myers, Masato Mutoh, Edward A. Sausville, Saijun Fan, Ann Monks, Patrick M. O'Connor, Insoo Bae, Characterization of the p53 Tumor Suppressor Pathway in Cell Lines of the National Cancer Institute Anticancer Drug Screen and Correlations with the Growth-Inhibitory Potency of 123 Anticancer Agents Cancer Research. ,vol. 57, pp. 4285- 4300 ,(1997)
Kornelia Polyak, Yong Xia, Jay L. Zweier, Kenneth W. Kinzler, Bert Vogelstein, A model for p53-induced apoptosis Nature. ,vol. 389, pp. 300- 305 ,(1997) , 10.1038/38525
A. A. Ruefli, M. J. Ausserlechner, D. Bernhard, V. R. Sutton, K. M. Tainton, R. Kofler, M. J. Smyth, R. W. Johnstone, The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 10833- 10838 ,(2001) , 10.1073/PNAS.191208598
Mark Wade, Yao-Cheng Li, Geoffrey M Wahl, None, MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nature Reviews Cancer. ,vol. 13, pp. 83- 96 ,(2013) , 10.1038/NRC3430
Qi-Bing Mei, The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways. Oncology Reports. ,vol. 28, pp. 384- 388 ,(2012) , 10.3892/OR.2012.1793
K. Bajbouj, C. Mawrin, R. Hartig, J. Schulze-Luehrmann, A. Wilisch-Neumann, A. Roessner, R. Schneider-Stock, P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells. Journal of Neuro-oncology. ,vol. 107, pp. 503- 516 ,(2012) , 10.1007/S11060-011-0791-2
Scott W. Lowe, H.Earl Ruley, Tyler Jacks, David E. Housman, p53-dependent apoptosis modulates the cytotoxicity of anticancer agents Cell. ,vol. 74, pp. 957- 967 ,(1993) , 10.1016/0092-8674(93)90719-7
Jeena Joseph, Narendra Wajapeyee, Kumaravel Somasundaram, Role of p53 status in chemosensitivity determination of cancer cells against histone deacetylase inhibitor sodium butyrate. International Journal of Cancer. ,vol. 115, pp. 11- 18 ,(2005) , 10.1002/IJC.20842
M. Nguyen, R. C. Marcellus, A. Roulston, M. Watson, L. Serfass, S. R. Murthy Madiraju, D. Goulet, J. Viallet, L. Belec, X. Billot, S. Acoca, E. Purisima, A. Wiegmans, L. Cluse, R. W. Johnstone, P. Beauparlant, G. C. Shore, Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 19512- 19517 ,(2007) , 10.1073/PNAS.0709443104
Turid Aas, Anne-Lise Børresen, Stephanie Geisler, Birgitte Smith-Sørensen, Hilde Johnsen, Jan E. Varhaug, Lars A. Akslen, Per E. Lønning, Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients Nature Medicine. ,vol. 2, pp. 811- 814 ,(1996) , 10.1038/NM0796-811